Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Recipient risk factors and lung transplant outcomes.

Vandervest KM, Zamora MR.

Curr Opin Organ Transplant. 2013 Oct;18(5):531-6. doi: 10.1097/MOT.0b013e32836519ec. Review.

PMID:
23995373
2.

Late-onset cytomegalovirus (CMV) in lung transplant recipients: can CMV serostatus guide the duration of prophylaxis?

Schoeppler KE, Lyu DM, Grazia TJ, Crossno JT Jr, Vandervest KM, Zamora MR.

Am J Transplant. 2013 Feb;13(2):376-82. doi: 10.1111/j.1600-6143.2012.04339.x. Epub 2012 Dec 3.

3.

Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA.

Mol Cancer Res. 2010 Jun;8(6):833-43. doi: 10.1158/1541-7786.MCR-09-0400. Epub 2010 May 25.

4.

A 76-year-old woman with acute CNS symptoms and pulmonary nodules.

Vandervest KM, Schwarz MI.

Chest. 2009 Dec;136(6):1686-1689. doi: 10.1378/chest.09-1180. No abstract available.

PMID:
19995771

Supplemental Content

Loading ...
Support Center